BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vllasaliu D, Thanou M, Stolnik S, Fowler R. Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery. Expert Opin Drug Deliv 2018;15:759-70. [PMID: 30033780 DOI: 10.1080/17425247.2018.1504017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Sadeghi S, Lee WK, Kong SN, Shetty A, Drum CL. Oral administration of protein nanoparticles: An emerging route to disease treatment. Pharmacological Research 2020;158:104685. [DOI: 10.1016/j.phrs.2020.104685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Cote B, Rao D, Alani AWG. Nanomedicine for Drug Delivery throughout the Alimentary Canal. Mol Pharm 2021. [PMID: 33605146 DOI: 10.1021/acs.molpharmaceut.0c00694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Elbialy NS, Mohamed N. Fabrication of the quaternary nanocomplex curcumin-casein-alginate-chitosan as a potential oral delivery system for cancer nutraceutical therapy. Journal of Drug Delivery Science and Technology 2022;70:103226. [DOI: 10.1016/j.jddst.2022.103226] [Reference Citation Analysis]
4 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abeer MM, Rewatkar P, Qu Z, Talekar M, Kleitz F, Schmid R, Lindén M, Kumeria T, Popat A. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. Journal of Controlled Release 2020;326:544-55. [DOI: 10.1016/j.jconrel.2020.07.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
6 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Aprodu A, Mantaj J, Raimi-Abraham B, Vllasaliu D. Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics 2019;11:E127. [PMID: 30893796 DOI: 10.3390/pharmaceutics11030127] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
8 Wang X, Wu J, Liu X, Tang K, Cheng L, Li J, Tang Y, Song X, Wang X, Li C. Engineered liposomes targeting the gut-CNS Axis for comprehensive therapy of spinal cord injury. J Control Release 2021;331:390-403. [PMID: 33485884 DOI: 10.1016/j.jconrel.2021.01.032] [Reference Citation Analysis]
9 Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw PT, Williams GR, Brocchini S, Awwad S. Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 2020;12:E999. [PMID: 33096803 DOI: 10.3390/pharmaceutics12100999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933 [DOI: 10.3748/wjg.v28.i18.1922] [Reference Citation Analysis]
11 Weaver E, Uddin S, Cole DK, Hooker A, Lamprou DA. The Present and Future Role of Microfluidics for Protein and Peptide-Based Therapeutics and Diagnostics. Applied Sciences 2021;11:4109. [DOI: 10.3390/app11094109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chen Y, Shan X, Luo C, He Z. Emerging nanoparticulate drug delivery systems of metformin. J Pharm Investig 2020;50:219-30. [DOI: 10.1007/s40005-020-00480-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
13 Dhalla AK, Al-Shamsie Z, Beraki S, Dasari A, Fung LC, Fusaro L, Garapaty A, Gutierrez B, Gratta D, Hashim M, Horlen K, Karamchedu P, Korupolu R, Liang E, Ong C, Owyang Z, Salgotra V, Sharma S, Syed B, Syed M, Vo AT, Abdul-Wahab R, Wasi A, Yamaguchi A, Yen S, Imran M. A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects. Drug Deliv Transl Res 2021. [PMID: 33604838 DOI: 10.1007/s13346-021-00938-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Zhai J, Mantaj J, Vllasaliu D. Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules. Pharmaceutics 2018;10:E188. [PMID: 30326565 DOI: 10.3390/pharmaceutics10040188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Kaffash E, Ali Shahbazi M, Hatami H, Nokhodchi A. An insight into gastrointestinal macromolecule delivery using physical oral devices. Drug Discov Today 2022:S1359-6446(22)00162-3. [PMID: 35460891 DOI: 10.1016/j.drudis.2022.04.014] [Reference Citation Analysis]
16 Wahlich J, Desai A, Greco F, Hill K, Jones AT, Mrsny RJ, Pasut G, Perrie Y, Seib FP, Seymour LW, Uchegbu IF. Nanomedicines for the Delivery of Biologics. Pharmaceutics 2019;11:E210. [PMID: 31058802 DOI: 10.3390/pharmaceutics11050210] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
17 Abramson A, Caffarel-Salvador E, Soares V, Minahan D, Tian RY, Lu X, Dellal D, Gao Y, Kim S, Wainer J, Collins J, Tamang S, Hayward A, Yoshitake T, Lee HC, Fujimoto J, Fels J, Frederiksen MR, Rahbek U, Roxhed N, Langer R, Traverso G. A luminal unfolding microneedle injector for oral delivery of macromolecules. Nat Med 2019;25:1512-8. [PMID: 31591601 DOI: 10.1038/s41591-019-0598-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
18 Stewart F, Cummins G, Turcanu MV, Cox BF, Prescott A, Clutton E, Newton IP, Desmulliez MPY, Thanou M, Mulvana H, Cochran S, Näthke I. Ultrasound mediated delivery of quantum dots from a proof of concept capsule endoscope to the gastrointestinal wall. Sci Rep 2021;11:2584. [PMID: 33510366 DOI: 10.1038/s41598-021-82240-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Angsantikul P, Peng K, Curreri AM, Chua Y, Chen KZ, Ehondor J, Mitragotri S. Ionic Liquids and Deep Eutectic Solvents for Enhanced Delivery of Antibodies in the Gastrointestinal Tract. Adv Funct Mater 2021;31:2002912. [DOI: 10.1002/adfm.202002912] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
20 Yellepeddi VK, Ghandehari H. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers. Expert Opinion on Drug Delivery 2019;16:1051-61. [DOI: 10.1080/17425247.2019.1656607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
21 Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacol Ther 2021;:108022. [PMID: 34687769 DOI: 10.1016/j.pharmthera.2021.108022] [Reference Citation Analysis]
22 Borges GSM, Lima FA, Carneiro G, Goulart GAC, Ferreira LAM. All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33896323 DOI: 10.1080/17425247.2021.1919619] [Reference Citation Analysis]
23 Uboldi M, Melocchi A, Moutaharrik S, Palugan L, Cerea M, Foppoli A, Maroni A, Gazzaniga A, Zema L. Administration strategies and smart devices for drug release in specific sites of the upper GI tract. J Control Release 2022;348:537-52. [PMID: 35690278 DOI: 10.1016/j.jconrel.2022.06.005] [Reference Citation Analysis]
24 Allmendinger A. Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products. Pharm Res 2021;38:739-57. [PMID: 33903976 DOI: 10.1007/s11095-021-03037-5] [Reference Citation Analysis]
25 Homayun B, Lin X, Choi HJ. Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals. Pharmaceutics 2019;11:E129. [PMID: 30893852 DOI: 10.3390/pharmaceutics11030129] [Cited by in Crossref: 152] [Cited by in F6Publishing: 106] [Article Influence: 50.7] [Reference Citation Analysis]
26 Luo Z, Paunović N, Leroux JC. Physical methods for enhancing drug absorption from the gastrointestinal tract. Adv Drug Deliv Rev 2021;175:113814. [PMID: 34052229 DOI: 10.1016/j.addr.2021.05.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Liang W, Pan HW, Vllasaliu D, Lam JKW. Pulmonary Delivery of Biological Drugs. Pharmaceutics 2020;12:E1025. [PMID: 33114726 DOI: 10.3390/pharmaceutics12111025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
28 Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material Engineering in Gut Microbiome and Human Health. Research 2022;2022:1-32. [DOI: 10.34133/2022/9804014] [Reference Citation Analysis]
29 Lapuhs P, Fuhrmann G. Engineering Strategies for Oral Therapeutic Enzymes to Enhance Their Stability and Activity. Adv Exp Med Biol 2019;1148:151-72. [PMID: 31482499 DOI: 10.1007/978-981-13-7709-9_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Pazhanimala SK, Vllasaliu D, Raimi-abraham BT. Engineering Biomimetic Gelatin Based Nanostructures as Synthetic Substrates for Cell Culture. Applied Sciences 2019;9:1583. [DOI: 10.3390/app9081583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pazhanimala S, Vllasaliu D, Raimi-abraham B. Electrospun Nanometer to Micrometer Scale Biomimetic Synthetic Membrane Scaffolds in Drug Delivery and Tissue Engineering: A Review. Applied Sciences 2019;9:910. [DOI: 10.3390/app9050910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
32 Korie NP, Tandoh KZ, Kwofie SK, Quaye O. Therapeutic potential of HIV-1 entry inhibitor peptidomimetics. Exp Biol Med (Maywood) 2021;246:1060-8. [PMID: 33596698 DOI: 10.1177/1535370221990870] [Reference Citation Analysis]
33 Coffey JW, Gaiha GD, Traverso G. Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. Annu Rev Pharmacol Toxicol 2021;61:517-40. [PMID: 32466690 DOI: 10.1146/annurev-pharmtox-030320-092348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Murtaza G. Recent strategies driving oral biologic administration. Expert Rev Vaccines 2021;:1-15. [PMID: 34612121 DOI: 10.1080/14760584.2021.1990044] [Reference Citation Analysis]